RE: LD quote22 Nov 2022 08:21
I wonder how far away from being self funding/ partially self funding Scancell actually is?
There's indicators that the company's funded until early 2024, so maybe, just maybe there's potential for some real commercialisation during the next calendar year when hopefully some Data might give a boost to the company's coffers.
Now THAT would be handy.
The very idea of Scancell producing a positive cash flow (either Income or Capital) would create a seachange in the way the Market views the stock.
Maybe we have to wait a bit longer but the cashflow situation is (IMO) possibly the greatest point of interest for me over the next two to three years. In this connection don't forget the CLNs.
AIMO